Meeder Asset Management Inc Ligand Pharmaceuticals Inc Transaction History

Meeder Asset Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $0 - $645	6 Added 23.08%	32 $3,000
Q2 2022 Aug 08, 2022	BUY	$74.52 - $117.06 $1,341 - $2,107	18 Added 225.0%	26 $2,000
Q4 2021 Feb 11, 2022	SELL	$127.69 - $165.85 $31,667 - $41,130	-248 Reduced 96.88%	8 $1,000
Q3 2021 Nov 08, 2021	BUY	$102.33 - $144.73 $4,707 - $6,657	46 Added 21.9%	256 $35,000
Q2 2021 Aug 09, 2021	BUY	$113.03 - $155.64 $10,398 - $14,318	92 Added 77.97%	210 $27,000
Q1 2021 Apr 28, 2021	BUY	$99.52 - $215.83 $3,582 - $7,769	36 Added 43.9%	118 $18,000
Q4 2020 Feb 09, 2021	SELL	$80.55 - $106.05 $279,186 - $367,569	-3,466 Reduced 97.69%	82 $8,000
Q3 2020 Nov 02, 2020	BUY	$89.56 - $126.72 $23,912 - $33,834	267 Added 8.14%	3,548 $338,000
Q2 2020 Aug 11, 2020	SELL	$68.28 - $123.65 $199,036 - $360,439	-2,915 Reduced 47.05%	3,281 $367,000
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $392,640 - $668,424	6,196 New	6,196 $450,000
Q4 2018 Jan 17, 2019	SELL	$128.36 - $272.13 $23,874 - $50,616	-186 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$211.18 - $274.49 $15,627 - $20,312	74 Added 66.07%	186 $0
Q2 2018 Jul 24, 2018	BUY	$150.77 - $207.98 $16,886 - $23,293	112 New	112 $0
Q1 2018 May 03, 2018	SELL	$138.63 - $182.62 $4,436 - $5,843	-32 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$128.36 - $147.04 $513 - $588	4 Added 14.29%	32 $4,000
Q3 2017 Oct 20, 2017	BUY	$120.91 - $137.94 $3,385 - $3,862	28	28 $4,000

277

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.